Brenntag Se · XETR:BNR
Brenntag — Investor Presentation (August 2026)
79 slides from Brenntag's investor presentation, August 2026
Slide 1: Investor Presentation August 2026
Investor Presentation August 2026
Slide 2: Agenda
1 Investor 1. Investment Highlights Presentation 2. Chemical Distribution Business Model and Industry Dynamics 3. Strategic Priorities and Divisional Framework 4. Sustainability 1 5. Financials Q2 2026 6. Outlook 1
Slide 3: Investment Highlights
Investment Highlights 1
Slide 4: Undisputed leader in a structurally expanding market, delivering reliable earnings growth
Brenntag is the undisputed leader in a structurally expanding market, delivering reliable earnings growth Our unique platform Delivering on our strategy Global leader with superior offering Resilient and reliable growth with in attractive markets ~4% Op. EBITA CAGR since IPO Operating EBITA Unparall
Slide 5: Two global divisions: Brenntag Specialties and Brenntag Essentials
Two global divisions: Brenntag Specialties and Brenntag Essentials Brenntag Specialties Brenntag Essentials EUR 1.1bn EUR 387m EUR 2.7bn EUR 659m FY 2025 Op. Gross Profit FY 2025 Operating EBITA FY 2025 Op. Gross Profit FY 2025 Operating EBITA 1,000’s ~100k 1,000’s ~150k Suppliers Customers Supplier
Slide 6: Diversified global footprint with around 600 sites in over 70 countries
Brenntag operates a highly diversified global footprint with around 600 sites in over 70 countries ographies d markets Su ppliers Pro ducts stomers Ge En Cu Global Serving multiple > 10,000 1) > 20,000 2) ~ 160,000 3) coverage industries Largest geography Largest end market (Op. Gross Profit FY 2025
Slide 7: Track record of sustainable, resilient and accretive growth
Track record of sustainable, resilient and accretive growth Op. EBITA and ROCE 1) Op. EBITA in EURm ROCE CAGR ▪ Consistent growth profile ~4% 22% 18% 1,512 ▪ Ability to protect profitability 18% 17% even in macro downturns 18% 16% 16% 19% 16% 14% 1,265 17% 17% 14% 14% 1,082 1,102 11% ▪ ROCE signific
Slide 8: M&A is a core pillar of Brenntag's strategy and growth story
M&A is a core pillar of Brenntag’s strategy and growth story Compounding value creation over time 1) M&A since 2020 Essentials Life Science Material Science >EUR ~6.4bn of acquired revenue Lactor Oy EMEA >EUR ~4.2bn spent on >100 acquisitions Packaged Chemex Products Chemicals division ICC North ~8x
Slide 9: Capital allocation framework
Capital allocation framework Capex ▪ Reinvestment in the business through annual Capex ~ EUR 300m Capital allocation framework ▪ Continued investment in value -gen erating bolt -on M&A where strategically attractive M&A ▪ EUR 400 -500m annual M&A spend, implies contribution of ~3% annual Op. EBITA g
Slide 10: Our growth formula for 2027
Our growth formula for 2027 Key components contributing to our Op. EBITA CAGR Chemicals Growth multiplier Divisional Group cost and M&A market growth from outsourcing growth efficiency Contribution initiatives initiatives 2-4% ≤ 1% 2% 2% 3% Organic CAGR: 7 -9% Total CAGR: 10 -12% 1 10
Slide 11: Overview Investment highlights
Overview Investment highlights Brenntag: the undisputed and resilient leader of the chemical distribution industry Two global market leaders Superior business model with superior offering: Significant growth potential with resilience Brenntag Specialties & in an attractive industry through the downt
Slide 12: Chemical Distribution Business Model and Industry Dynamics
Chemical Distribution Business Model and Industry Dynamics 1
Slide 13: Distribution is an attractive and indispensable market, growing faster than manufacturing
Distribution is an attractive and indispensable market, growing faster than chemical manufacturing Distributors are an indispensable channel… …and are outpacing manufacturing growth Chemical suppliers Sales CAGR Reinforce suppliers' strategy, e.g., brand proposition, value versus % volume strategies
Slide 14: Distributors perform a value-added function with economies of scope and scale
Distributors perform a value -added function with economies of scope and scale for tail -ends of many verticals Know -how, Innovation & Purchase Sustainability Em Innovation & application development Sourcing from various suppliers, s/ r pl oy leveraging global scale and regional tic ato Drive suppl
Slide 15: Comparison of different ecosystem key constituents
Comparison of different ecosystem key constituents “What we are” “What we are not” Chemical Producer Business model B2B Services / solutions Manufacturing Product portfolio Broad, Essentials and Specialties Typically, more narrow Customer base Broad in diverse end - markets Often larger, key - accou
Slide 16: Undisputed global leader in a highly fragmented distribution market
Brenntag is the undisputed global leader in a highly fragmented chemical and ingredients distribution market Chemical and ingredients distribution sales -based market share (%), 2024 1) Top 6 have 11% market share 89% 100% ~5% Univar IMCD Azelis Kolmar Sinochem Rest of market Total market 1 1) Exclu
Slide 17: Brenntag growth & leadership drivers aligned with industry trends
Brenntag growth & leadership drivers aligned with industry trends Industry trends Brenntag growth & leadership drivers Stable outsourcing trend and share of value -added Attractive distribution market with mid - term underlying sales 1 services growth of 2 to 4% p.a. 1) Uneven economic development a
Slide 18: Consolidation in chemical distribution has accelerated
Consolidation in chemical distribution has accelerated… Global chemical distribution market sales Number of major acquisitions globally +60% Top 50 players have gained 10 % -points market share from 2017 - 2022 Others ~70% ~60% In 2023, five players out of the top 50 global chemical distributors exe
Slide 19: Strategic Priorities and Divisional Framework
Strategic Priorities and Divisional Framework 1
Slide 20: Continued execution of our key priorities delivering first green shoots
Continued execution of our key priorities delivering first green shoots I. Sales ▪ Sales productivity continuing to improve through intensified commercial focus ▪ Commercial initiatives are starting to provide results: • Increase in number of active customers of ~1,000 in North America • Global roll
Slide 21: Middle East crisis: Brenntag is ensuring supply in a volatile environment
Middle East crisis: Brenntag is ensuring supply in a volatile and disrupted environment End markets in view of exposure Price increases more than offset Current crisis amplifies role of to oil -prices in disrupted markets Brenntag Op. Gross Profit FY 2025 Previous cycle in 2021/2022 Pricing offset u
Slide 22: Distinct, high performing businesses aligned with business drivers
Distinct, high performing businesses aligned with business drivers and market requirements Brenntag Essentials Brenntag Specialties Business steered by Regions Business steered by Global End Markets Regional Segments 1) Global Industry Customized solutions Segments 1) Cost efficiency APAC and expert
Slide 23: Brenntag Essentials is a market leading, global and diversified platform
Brenntag Essentials is a market leading, global and diversified platform ▪ The global market leader in industrial chemicals distribution Market leader ▪ Generating an Operating Gross Profit of EUR 2.6 billion in FY 2025 ▪ Operating in more than 60 countries globally Global reach ▪ Broad and diversif
Slide 24: Brenntag Essentials: Unleashing the true potential of the platform
Brenntag Essentials: Unleashing the true potential of the platform Executing our ‘Triple’ strategy to unleash the potential of BES’s unrivalled platform Resilient and Unleashing Brenntag M&A as an structurally growing Essentials’ true potential accelerator Last Mile Service Regional Sourcing and Glo
Slide 25: Brenntag Specialties: most comprehensive global network of Innovation & Application Centers
Brenntag Specialties is connecting the most comprehensive global network of Innovation & Application Centers # of I&ACs I&AC by end market Material Europe Science Life Science North 10 America 20 28 Asia Pacific Strategy to optimize network 4 Middle East Enhance global connectivity 2 >70 I&ACs Scale
Slide 26: Brenntag Specialties: Power to perform
Brenntag Specialties: Power to perform Clear and comprehensive strategy to accelerate BSP’s financial performance and close the performance gap Optimizing Closing BSP’s Delivering BSP’s platform performance gap consistent growth Focused M&A to Initiatives Expand margins Prioritize cost base Drive pr
Slide 27: Broad overview of Brenntag's product portfolio
Broad overview of Brenntag’s product portfolio Brenntag Group: Balanced portfolio of more than 20,000 products and ingredients combining scale (Industrial), growth & margin (Semi - specialties), and differentiation (True Specialties) Product Category True Specialties Semi Specialties Industrial Chem
Slide 28: Sustainability
Sustainability 1
Slide 29: Future Sustainable Brenntag picture
Based on our strengths and high ambitions, we developed a “Future Sustainable Brenntag” picture Responsible distribution ... … of sustainable chemicals and ingredients Brenntag’s operations & suppliers Brenntag’s products & services Climate protection Circular economy Strive for zero CO 2 emissions
Slide 30: Key mid-/long-term targets in six focus areas addressing the UN SDGs
Key mid -/long -term targets in six focus areas addressing the UN SDGs Focus areas Mid- to long -term targets 2025 - 2027 2030 - 2050 - 25% in Climate protection & Scope 1&2: Scope 3: Net - zero vs. 2023: 100% electricity consumption process spill emissions reduction - 58.8% vs. - 35% vs. Scope 1&2
Slide 31: We continue to lead the sustainability agenda with key initiatives in place
We continue to lead the sustainability agenda with key initiatives in place Unique carbon management program Carbon footprint calculator "CO 2 Xplorer" Global living wage policy Reduce footprint Improve handprint ▪ Salaries meet or exceed regional living C ustomers GHG Internal Suppliers + = footpri
Slide 32: Brenntag commits to reach net-zero GHG emissions across the value chain by 2050
Brenntag commits to reach net -zero GHG emissions across the value chain by 2050 CO 2 Emissions in 2025 Main contributor to CO 2 Emissions development in thousand tonnes reduction in thousand tonnes Scope 1 Scope 3 Scope 2 Target - 35% Scope 1 Company facilities, Target - 58.8% 176 0.73% company tru
Slide 33: Brenntag with leading ESG position
Brenntag with leading ESG position Memberships UN Responsible “Together for Global inclusion DAX ESG Reporting is Near - term and German and initiatives Global Care/Distribution Sustainability” initiative Target prepared by fully net - zero targets Sustainability Award Compact program initiative The
Slide 34: Financials Q2 2026
Financials Q2 2026 Ker B
Slide 35: Q2 2026 Highlights
Q2 2026 Highlights Strong operating performance and margin expansion Highlights Q2 2026 Sales EUR 4.3 bn ▪ Strong commercial execution and disciplined margin management * + 11.1% vs. PY ▪ Significant organic growth (GP +18%) mainly driven by Essentials Operating GP ▪ Positive pricing trends progress
Slide 36: Q2 2026 Financials
Q2 2026 Financials Strong earnings growth driven by all business units ▪ Demand remained resilient throughout Q2, Top -line Operating Operating broadly in line with mid - March levels performance GP GP Margin ▪ Disciplined pricing and margin EUR 1,146 m 26.9% management, supported by strong Gross Ma
Slide 37: Q2 2026 Divisions
Q2 2026 Divisions Strong margin expansion in both divisions Essentials Specialties Op. Gross Profit Q2 2026: EUR 836 m (23.1% vs. PY*) Op. Gross Profit Q2 2026: EUR 310 m (8.8% vs. PY*) Gross Margin development vs. PY ▪ Overall, demand levels sequentially holding + 2.2 pp up + 0.6 pp ▪ Volatility in
Slide 38: Q2 2026 Cost-out
Q2 2026 Cost -out C ost -out program well on track Key developments Effects from the cost -out program vs. 2025 cost base, in EUR m ▪ Effects from cost - out program amounting to EUR 41m in Q2 2026 ▪ Focused on sustained reduction in central costs - Organic reduction of ~500 FTE in 2026 - Decrease i
Slide 39: Q2 2026 Opex
Q2 2026 Opex Accelerated cost -out delivery and continuing cost discipline Key developments Q2 2026 Opex development YoY * In EUR m Cost -out efforts counter - balancing inflationary trends ▪ Opex increase YoY reflects strong operational performance 5 - Higher bonus provisions vs. prior year 15 - In
Slide 40: Q2 2026 Op. EBITDA
Q2 2026 Op. EBITDA Strong organic growth supported by positive pricing trends Key developments Op. EBITDA development YoY In EUR m ▪ Demand remained resilient despite continued geopolitical uncertainty + 40.9% * ▪ Strong commercial execution and margin management in Q2 2026 Acquisitions: EUR - 4.7m
Slide 41: Mixed regional market conditions: Customers remain prudent
Mixed regional market conditions: Customers remain prudent North America EMEA ▪ Resilient demand in key end markets ▪ Structural pressures persist, higher pricing ▪ Supplier - led price increases in both levels mitigate labor and energy costs industrial and specialty chemicals ▪ Demand environment r
Slide 42: Cautious market outlook persists across divisions and segments
Cautious market outlook persists across divisions and segments Brenntag EMEA North America Latin America APAC Essentials ▪ End - market ▪ Demand outlook ▪ Demand outlook ▪ Pricing to demand remains remains healthy remains stable normalize further subdued across ▪ Pricing expected ▪ Chinese product r
Slide 43: Outlook
Outlook 1
Slide 44: Operating EBITDA guidance 2026 raised
Operating EBITDA guidance 2026 raised Guidance ▪ Brenntag currently expects an Operating EBITDA for the 2026 financial year: At a range of EUR 1,350 –1,450 million ▪ The outlook incorporates the solid start to the third quarter, reinforcing confidence for the remainder of the year ▪ At the same time
Slide 45: Appendix
Appendix 1
Slide 46: From 1874 to 2024: 150 years of being constantly agile
From 1874 to 2024 150 years of being constantly agile 1874 1966 Philipp Mühsam Brenntag becomes founded agricultural international (Belgium) 2020 trading business Horizon 1 Project Brenntag 2006-2010 Private-Equity 1920s owned by BC 2022 Launch of Partners Horizon 2 the gasoline 2010 Strategy to Win
Slide 47: Board of Management
Board of Management Jens Birgersson Thomas Reisten Chief Executive Officer Chief Financial Officer ▪ Brenntag Essentials ▪ Accounting Brenntag Group and Corporate ICS & Risk ▪ Brenntag Specialties Management ▪ Corporate Board Office ▪ Controlling ▪ Corporate Planning, Strategy & M&A Brenntag Group ▪
Slide 48: Brenntag Executive Committee led by the Board of Management
Brenntag Executive Committee led by the Board of Management Key rationale CEO CFO COO CHRO CCO CIO ✓ Lean governance ✓ Efficient decision making ✓ Reduced hierarchy layers Global ✓ Established and President experienced Global Global Global leaders President President President Pharma / President Pre
Slide 49: ESG: Safety and Diversity
ESG: Safety and Diversity Group Accident Rate Diversity – Key figures TRIR 1) Target Target Achievement Level 2) 2030 3) 2025 3) 2025 3) 4.2 4.0 L1 >30% ≥23,0% 41,7% Target: < 2.0 by 2030 3.2 3.1 L2 >30% ≥27.6% 33.8% 2.7 2.6 Target 2.5 < 2.2 2.1 L3 >30% ≥30.0% 44,1% L4 >30% ≥30.0% 42,4% L5 >30% ≥27.
Slide 50: 2025 ESG target achievement
2025 ESG target achievement 2025 2025 Objective KPI Reference to mid -/long -term target target results Incorporating expanded social and Procurement process: Develop roadmap for • All suppliers share our vision on human rights and environmental criteria into strategic sustainability integration don
Slide 51: Financials Q2 2026 Income statement
Financials Q2 2026 Income statement in EUR m Q2 2026 Q2 2025 ∆ ∆ FX adjusted Sales 4,263 3,869 10.2% 11.1% Cost of materials - 3,117 - 2,895 - 7.7% - 8.4% Operating Gross Profit 1,146 974 17.7 % 18.9 % Operating expenses - 682 - 640 6.7% 7.4% Operating EBITDA 463 334 38.8 % 40.9 % Depreciation - 95
Slide 52: Financials Q2 2026 Operating EBITDA bridge
Financials Q2 2026 Operating EBITDA bridge Operating EBITDA 1) growth by division, Q2 2026 Operating EBITDA 1) growth by division, H1 2026 in EUR m in EUR m + 18.3% + 47.2% + 40.9% + 10.2% + 18.1% + 16.1% 2 3 -2 -4 86 113 1 22 - 19 0 -5 20 -7 -1 463 770 334 689 Q2 2025 Brenntag Brenntag Group and Q2
Slide 53: Financials Q2 2026 Segments
Financials Q2 2026 Segments 1) 2) Operating EBITDA Operating Gross Profit Operating EBITDA conversion ratio ∆ FX ∆ FX in EUR m Q2 2026 Q2 2025 ∆ adjusted Q2 2026 Q2 2025 ∆ adjusted Q2 2026 Q2 2025 Specialties Life Science 203 199 1.8% 2.2% 80 80 0.9% 1.6% 39.5% 39.8% Specialties Material Science 105
Slide 54: Financials Q2 2026 Cash flow statement
Financials Q2 2026 Cash flow statement in EUR m Q2 2026 Q2 2025 Profit after tax 182 43 Effect from IAS 29 on profit/loss after tax 1 - Depreciation & amortization 113 197 Income tax expense 80 39 Income taxes paid - 65 - 66 Net interest expense 39 35 Interest paid - 55 - 57 (thereof interest paid f
Slide 55: Financials Q2 2026 Cash flow statement (continued)
Financials Q2 2026 Cash flow statement (continued) in EUR m Q2 2026 Q2 2025 Proceeds from the disposal of consolidated subsidiaries and other business units less costs to sell - 19 Proceeds from the disposal of other financial assets - - Proceeds from the disposal of intangible assets and property,
Slide 56: Financials Q2 2026 Free cash flow
Financials Q2 2026 Free cash flow in EUR m Q2 2026 Q2 2025 ∆ abs ∆% Operating EBITDA 463 334 129 38.6 Payments to acquire intangible assets and property, plant and equipment - 64 - 66 2 - 3.0 ∆ Working capital 1) - 73 - 280 >100 - 353 Principal and interest payments on lease liabilities - 42 - 41 -1
Slide 57: Financials Q2 2026 Working capital
Financials Q2 2026 Working capital in EUR m 30 Jun 2026 31 Mar 2026 31 Dec 2025 30 Sep 2025 30 Jun 2025 Inventories 1,653 1,387 1,351 1,412 1,479 + Trade receivables 2,729 2,388 2,040 2,211 2,300 ./. Trade payables 1,970 1,741 1,498 1,571 1,634 Working capital (end of period) 1) 2,412 2,034 1,893 2,
Slide 58: Financials Q2 2026 Balance sheet overview
Financials Q2 2026 Balance sheet overview Assets Equity and Liabilities in EURm in EURm 11,671 11,671 10,626 10,626 Trade payables Cash & equiv. 509 1,970 Trade receivables 798 2,729 1,498 Financial liabilities 2,040 Inventories 3,021 1,653 2,785 Lease liabilities 1,351 Other liabilities PPE 588 Pro
Slide 59: Financials Q2 2026 Balance sheet and maturity profile
Financials Q2 2026 Balance sheet and maturity profile in EUR m 1) Eurobond & Eurobond in EUR m 30 Jun 2026 31 Dec 2025 Promissory Note Financial liabilities 3,021 2,785 Eurobond Eurobond Lease liabilities 588 541 ./. Cash and cash equivalents 509 798 Promissory Syndicated Note Loan Net Debt 3,100 2,
Slide 60: Financials H1 2026 Income statement
Financials H1 2026 Income statement in EUR m H1 2026 H1 2025 ∆ ∆ FX adjusted Sales 7,925 7,941 - 0.2% 3.0% Cost of materials - 5,829 - 5,947 2.0% - 1.0% Operating Gross Profit 2,096 1,994 5.2% 8.8% Operating expenses - 1,326 - 1,305 1.7 % 4.9% Operating EBITDA 770 689 11.7 % 16.1% Depreciation - 185
Slide 61: Financials Segments H1 2026
Financials H1 2026 Segments 1) 2) Operating EBITDA Operating Gross Profit Operating EBITDA conversion ratio ∆ FX ∆ FX in EUR m H1 2026 H1 2025 ∆ adjusted H1 2026 H1 2025 ∆ adjusted H1 2026 H1 2025 Specialties Life Science 397 411 - 3.4% - 0.7% 163 166 - 1.9% 1.5% 40.4% 39.8% Specialties Material Sci
Slide 62: Financials H1 2026 Cash flow statement
Financials H1 2026 Cash flow statement in EUR m H1 2026 H1 2025 Profit after tax 281 179 Effect from IAS 29 on profit/loss after tax 3 4 Depreciation & amortization 218 307 Income tax expense 128 96 Income taxes paid - 118 - 117 Net interest expense 75 70 Interest paid - 77 - 82 (thereof interest pa
Slide 63: Financials H1 2026 Cash flow statement (continued)
Financials H1 2026 Cash flow statement (continued) in EUR m H1 2026 H1 2025 Proceeds from the disposal of consolidated subsidiaries and other business units less costs to sell 1 19 Proceeds from the disposal of other financial assets 1 - Proceeds from the disposal of intangible assets and property,
Slide 64: Financials H1 2026 Free cash flow
Financials H1 2026 Free cash flow in EUR m H1 2026 H1 2025 ∆ abs ∆% Operating EBITDA 770 689 81 11.8 Payments to acquire intangible assets and property, plant and equipment - 123 - 126 3 - 2.4 ∆ Working capital 1) - 157 - 303 >100.0 - 460 Principal and interest payments on lease liabilities - 90 - 9
Slide 65: Financials FY 2025 Income statement
Financials FY 2025 Income statement in EUR m FY 2025 FY 2024 ∆ ∆ FX adjusted Sales 15,171.5 16,237.4 - 6.6% - 3.7% Cost of materials - 11,339.8 - 12,212.0 - 7.1% - 4.3% Operating Gross Profit 3,831.7 4,025.4 - 4.8% - 1.9% Operating expenses - 2,544.2 - 2,568.6 - 0.9% 1.9% Operating EBITDA 1,287.5 1,
Slide 66: Financials Segments FY 2025
Financials FY 2025 Segments 1) 2) Operating EBITDA Operating Gross Profit Operating EBITDA conversion ratio ∆ FX ∆ FX in EUR m FY 2025 FY 2024 ∆ adjusted FY 2025 FY 2024 ∆ adjusted FY 2025 FY 2024 Specialties Life Science 775.8 829.9 - 6.5% - 3.5% 293.8 338.3 - 13.2% - 9.8% 37.9% 40.8% Specialties M
Slide 67: Financials FY 2025 Cash flow statement
Financials FY 2025 Cash flow statement in EUR m FY 2025 FY 2024 Profit after tax 269.7 543.7 Effect from IAS 29 on profit/loss after tax 8.1 4.2 Depreciation & amortization 589.3 444.1 Income tax expense 215.7 198.9 Income taxes paid - 174.7 - 229.6 Net interest expense 138.0 133.7 Interest paid - 1
Slide 68: Financials FY 2025 Cash flow statement (continued)
Financials FY 2025 Cash flow statement (continued) in EUR m FY 2025 FY 2024 Proceeds from the disposal of consolidated subsidiaries and other business units less costs to sell 19.5 - Proceeds from the disposal of other financial assets 1.4 0.4 Proceeds from the disposal of intangible assets and prop
Slide 69: Financials FY 2025 Free cash flow
Financials FY 2025 Free cash flow in EUR m FY 2025 FY 2024 ∆ abs ∆% Operating EBITDA 1,287.5 1,456.8 - 169.3 - 11.6 Payments to acquire intangible assets and property, plant and equipment - 293.0 - 342.2 49.2 - 14.4 ∆ Working capital 1) 121.6 - 45.8 167.4 - 365.5 Principal and interest payments on l
Slide 70: Sound financial profile: compounding growth track record and resilience
Sound financial profile Compounding growth track record and resilience Sales Operating Gross Profit CAGR CAGR (EUR bn) (EUR m) +5.7% 4,319 +4.7% 19.4 4,042 4,025 3,832 16.8 16.2 3,379 14.4 15.2 12.6 12.8 11.8 2,822 2,869 2,554 2,661 9.7 9.8 10.0 10.3 10.5 11.7 2,322 2,429 2,078 7.4 7.6 8.7 1,808 1,9
Slide 71: Cash flow: strong cash generation over the past years
Cash flow Strong cash generation over the past years in EUR m 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 Op. EBITDA 1,287.5 1,456.8 1,584.6 1,808.6 1,344.6 1,057.7 1,001.5 875.5 836.0 810.0 807.4 726.7 696.8 707.0 658.8 597.6 CAPEX - 293.0 - 342.2 - 321.1 - 267.2
Slide 72: ROCE: Increasing value added and returns
ROCE Increasing value added and returns in EUR m 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 Op. EBITA 929.3 1,101.9 1,265.0 1,511.7 1,081.9 805.3 757.9 753.5 717.1 694.5 698.7 627.3 597.1 610.8 572.0 518.6 EBITA 822.8 990.5 1,186,7 1,491.9 853.2 758.1 766.5 770.9
Slide 73: Strong dividend track record
Strong dividend track record Dividend Policy Pay an annual dividend of 35% to 50% of consolidated profit after tax attributable to shareholders of Brenntag SE Dividend in FY 2025 Profit after tax in FY 2025 impacted by one - off items +10% CAGR 2.10 2.10 2.00 1.90 1.45 1.35 1.20 1.25 1.05 1.10 1.00
Slide 74: Brenntag's Historic Leverage & Credit Rating
Brenntag’s Historic Leverage & Credit Rating Leverage: Net Debt / Operating EBITDA 5.6 IPO IFRS 16 4.8 3.6 2.4 2.3 2.3 2.1 1.9 1.9 2.1 2.1 1.9 2.0 1.9 1.9 2.0 1.3 1.5 1.4 1.1 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Q2 2026 S&P B B+ BB+ BBB
Slide 75: Bond data
Bond data Bond 2028 Bond 2029 Bond 2031 Bond 2032 Issuer Brenntag Finance B.V. Brenntag Finance B.V. Brenntag Finance B.V. Brenntag Finance B.V. Luxembourg Stock Luxembourg Stock Luxembourg Stock Luxembourg Stock Listing Exchange Exchange Exchange Exchange ISIN XS2802928775 XS2394063437 XS3193854281
Slide 76: Share price performance versus DAX, STOXX Europe 600 Chemicals and peers
Share price performance versus DAX, STOXX Europe 600 Chemicals and peers since 2021 Performance Indexed (Jan. 1st 2021 = 100) 200 + 90% 180 + 82% 160 140 120 + 11% 100 - 16% 80 - 24% 60 - 53% 40 Jan-21 Jul-21 Jan-22 Jul-22 Jan-23 Jul-23 Jan-24 Jul-24 Jan-25 Jul-25 Jan-26 Brenntag DAX STOXX Europe 60
Slide 77: Brenntag Share & Shareholder Structure
Brenntag Share & Shareholder Structure Share data Analysts’ Opinions 2) ISIN; Stock Symbol; Listed since DE000A1DAHH0; BNR; 29 March 2010 Click to view current consensus Subscribed capital; Outstanding Shares EUR 144,385,372; 144,385,372 Click to view Buy current consensus Class of shares; Free floa
Slide 78: Investor Relations
Investor Relations Financial calendar Financial Publications Sustainability Publications November 11, 2026 November 12, 2026 9M 2026 Capital Markets Day Interim Statement March 10, 2027 May 12, 2027 Financial News Corporate Governance FY 2026 3M 2027 Annual Report Interim Statement Contact Capital M
Slide 79: Disclaimer
Disclaimer This presentation may contain forward - looking statements based on current assumptions and forecasts made by Brenntag SE and other information currently available to the company . Various known and unknown risks, uncertainties and other factors could lead to material differences between